ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04621	NOD-like receptor signaling pathway	11/60	157/7206	5.051044831e-08
ko05152	Tuberculosis	10/60	187/7206	2.66099344499e-06
ko04668	TNF signaling pathway	8/60	120/7206	5.80791121022e-06
ko05168	Herpes simplex infection	9/60	182/7206	1.67108490578e-05
ko04620	Toll-like receptor signaling pathway	7/60	100/7206	1.69734074172e-05
ko05131	Shigellosis	6/60	82/7206	5.53538037388e-05
ko04217	Necroptosis	8/60	178/7206	0.00010117087623
ko04210	Apoptosis	8/60	180/7206	0.000109402771017
ko04380	Osteoclast differentiation	7/60	134/7206	0.000111688685383
ko05167	Kaposi's sarcoma-associated herpesvirus infection	8/60	191/7206	0.00016525509782
ko05161	Hepatitis B	7/60	173/7206	0.000538025781626
ko04660	T cell receptor signaling pathway	6/60	124/7206	0.000538752848159
ko05321	Inflammatory bowel disease (IBD)	4/60	56/7206	0.00115487389104
ko04658	Th1 and Th2 cell differentiation	5/60	96/7206	0.00115699810271
ko05160	Hepatitis C	6/60	153/7206	0.00161557367078
ko04622	RIG-I-like receptor signaling pathway	4/60	62/7206	0.00169012960002
ko04071	Sphingolipid signaling pathway	6/60	162/7206	0.00216073882215
ko05145	Toxoplasmosis	5/60	126/7206	0.0038232865625
ko04662	B cell receptor signaling pathway	4/60	88/7206	0.00601818856267
ko04215	Apoptosis - multiple species	3/60	47/7206	0.00686160331518
ko04064	NF-kappa B signaling pathway	4/60	96/7206	0.00816187257568
ko05100	Bacterial invasion of epithelial cells	4/60	99/7206	0.00908000504237
ko04611	Platelet activation	5/60	163/7206	0.0111731099735
ko05164	Influenza A	5/60	167/7206	0.0123179751934
ko05418	Fluid shear stress and atherosclerosis	5/60	173/7206	0.014181504467
ko04010	MAPK signaling pathway	7/60	321/7206	0.0165800362501
ko00073	Cutin, suberine and wax biosynthesis	1/60	2/7206	0.0165846065132
ko04932	Non-alcoholic fatty liver disease (NAFLD)	5/60	182/7206	0.0173204900573
ko01522	Endocrine resistance	4/60	124/7206	0.0194158085372
ko04060	Cytokine-cytokine receptor interaction	5/60	191/7206	0.020892515402
ko05142	Chagas disease (American trypanosomiasis)	4/60	130/7206	0.0226632429159
ko04072	Phospholipase D signaling pathway	5/60	197/7206	0.0235248558021
ko04630	Jak-STAT signaling pathway	4/60	132/7206	0.0238152650383
ko01524	Platinum drug resistance	3/60	76/7206	0.0251094883544
ko05130	Pathogenic Escherichia coli infection	3/60	77/7206	0.0259759242131
ko04931	Insulin resistance	4/60	137/7206	0.0268497241236
ko04320	Dorso-ventral axis formation	2/60	31/7206	0.0271580108863
ko05212	Pancreatic cancer	3/60	83/7206	0.0315098171496
ko05166	HTLV-I infection	6/60	292/7206	0.0336745923112
ko04657	IL-17 signaling pathway	3/60	87/7206	0.0355166873823
ko04920	Adipocytokine signaling pathway	3/60	89/7206	0.037614615465
ko00562	Inositol phosphate metabolism	3/60	89/7206	0.037614615465
ko05222	Small cell lung cancer	3/60	89/7206	0.037614615465
ko05120	Epithelial cell signaling in Helicobacter pylori infection	3/60	92/7206	0.0408786505991
ko05132	Salmonella infection	3/60	98/7206	0.0478232255817